Michael Paul North - 16 Feb 2024 Form 4 Insider Report for AMEDISYS INC (AMED)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Feb 2024, 21:00:38 UTC
Prior SEC filing
08 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Jennifer Guckert Griffin, pursuant to a power of attorney

Key filing fact

Michael Paul North filed Form 4 for AMEDISYS INC (AMED) on 21 Feb 2024.

Key facts

  • This page summarizes Michael Paul North's Form 4 filing for AMEDISYS INC (AMED).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Feb 2024, 21:00.

Change

  • Previous filing in this sequence was filed on 08 Mar 2023.
  • Current net transaction value: -$149,061.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMED transaction

Common Stock

Award

Transaction value
$0
Shares
+8,277
Change %
+53%
Price
$0.000000
Shares after
23,932
Date
16 Feb 2024
Ownership
Direct
Footnotes
F1, F2, F3
AMED transaction

Common Stock

Tax liability

Transaction value
$149,061
Shares
-1,591
Change %
-6.6%
Price
$93.69
Shares after
22,341
Date
20 Feb 2024
Ownership
Direct
Footnotes
F2, F3
AMED holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
457
Date
16 Feb 2024
Ownership
Through 401(k) Plan
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Issuer awarded the Reporting Person 8,277 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/4 installments on each of February 16, 2025, 2026, 2027 and 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date.

Footnote F2

The number of shares in Column 5 reflects the addition of an aggregate of 11,250 shares of common stock issued to the Reporting Person upon the exercise of stock options on July 18, 2019 and July 24, 2019 that the Issuer discovered were incorrectly reported solely as open market sales without corresponding stock option exercises (rather than a cashless exercise of the stock options). The number of shares reported in this column reflects the Reporting Person's current total Table I holdings.

Footnote F3

The total amount of shares beneficially owned includes 1,633 shares held in an employee stock purchase plan account.

Footnote F4

The information in this report is based on a plan statement dated as of December 31, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .